To guarantee total protection for the eyes and ensure that patients are getting high-quality ophthalmic lenses, Essilor, the world’s leading ophthalmic optics company, advises consumers to be more discriminating when buying lenses that are touted as “transitions lenses.”
Transitions® is a trademark brand of photochromic lenses that performs as everyday clear lenses indoors and darkens when exposed outdoors especially to UV light.
Transitions® is a brand that is owned by Essilor International, which designs, manufactures and distributes a wide range of lenses in over 100 countries worldwide.
Here in the Philippines, the Transitions® brand is partnered with Crizal®, a globally recognized brand owned by Essilor International, known for its range of anti-reflective, anti-smudge and anti-static lenses. Anti-reflective lenses reduce glare from daytime lights and reflections from blue lights. They also provide protection against scratches, smudges, dust, water and other enemies of clear vision.
Crizal Transitions® lenses provide optimum vision solution. These genuine lenses are 30% faster to fade back to their clear state and conveniently offer a great contrast perception though glare reduction in any light.
The genuine Crizal Transitions® lenses come with an authenticity card upon purchase. With these premium lenses, you can rest assured that your eyes are protected and safe.
To learn more about Crizal Transitions® and other high-quality vision solutions provided by Essilor, visit www.essilor.com.ph.
The world’s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lenses that meet his or her unique visual requirements. To support this vision, the Company allocates over €160 million to research and development every year, in a commitment to continuously bring new, more effective products to market. Essilor’s flagship brands are Varilux®, Crizal®, Transitions®, Xperio® and OptifogTM.
It also develops and markets equipment, instruments and services for eyecare professionals.
Essilor reported consolidated revenue of nearly €5.7 billion in 2014 and employs 58,000 people. It markets its products in more than 100 countries and has 33 plants, 490 prescription laboratories and edging facilities, as well as several research and development centers around the world.
Essilor was classified by Forbes magazine as being among the world’s 30 most innovative companies.
For more information, please visit www.essilor.com.ph.